Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: XTRAVA, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-03-03 to 2023-03-03
Current total value of award: $5057000
Description: RADX TECH XTRAVA, INC. - SPERA COVID-19 AG TEST  RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #5834 XTRAVA, INC.